St. Jude Medical ( STJ ) Wednesday delivered record first-quarter revenue driven by strong sales growth in several product groups, and offered strong second-quarter earnings guidance. The Minnesota-based company had net income of $95.7 million, or 52 cents a share, vs. $80 million, or 43 cents a share, a year ago, The consensus estimate was for 50 cents a share, according to Thomson First Call. Revenue jumped 24% in the period to $548.6 million, led by sales of its implantable cardioverter defibrillators, pacemakers and vascular closure devices. The company expects EPS of 52 cents to 54 cents a share in the second quarter and $2.18 to $2.23 for full-year 2004. The consensus forecast is for 50 cents a share and $2.20 a share, respectively. Shares were recently up $1.74, or 2.3%, to $76.78.